Clinical Trial Update: To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing two formulations of AZD3241 on blood concentrations in healthy volunteers. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• AZD3241

Snippet

Sponsor: AstraZeneca | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED